Therefore, our team used second-generation sequencing to detect whole-exon susceptibility gene mutations and mutations in four breast cancer susceptibility genes (BRCA1, BRCA2, PALB2, and RECQL) in Chinese women. The gene discussed is BRCA2; the disease is breast carcinoma.